OCUP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.70%

Insider Buying (Last 12 Months): $74,100.00

Insider Selling (Last 12 Months): $0.00

Ocuphire Pharma Insider Trading History Chart

Ocuphire Pharma Share Price & Price History

^$1.54

▲ +0.03 (1.99%)

As of 04/23/2024 05:00 PM ET

Days: 30 | 90 | 365

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Ocuphire Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/21/2024	Joseph K Schachle	COO	Buy	2,000	$2.05	$4,100.00	2,000
3/21/2024	Nirav S Jhaveri	CFO	Buy	10,000	$2.10	$21,000.00	150,000
3/18/2024	George Magrath	CEO	Buy	25,000	$1.96	$49,000.00	425,000
5/20/2022	James S. J. Manuso	Director	Buy	5,000	$1.99	$9,950.00	21,570
5/19/2022	Mina Sooch	CEO	Buy	12,500	$2.07	$25,875.00	412,522
12/13/2021	Jay Pepose	Director	Buy	8,250	$3.65	$30,112.50
11/18/2021	James S. J. Manuso	Director	Buy	2,000	$3.50	$7,000.00
9/13/2021	Jay Pepose	Director	Buy	12,631	$4.75	$59,997.25

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

SEC Filings (Institutional Ownership Changes) for Ocuphire Pharma (NASDAQ:OCUP)

14.97% of Ocuphire Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocuphire Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/8/2024	Richmond Brothers Inc.	252,769	$0.76M	1.3%	-31.3%	1.117%
2/5/2024	Victory Capital Management Inc.	46,916	$0.14M	0.0%	N/A	0.207%
2/5/2024	Kestra Private Wealth Services LLC	42,341	$0.13M	0.0%	+323.4%	0.187%
11/13/2023	Acadian Asset Management LLC	49,563	$0.17M	0.0%	+75.5%	0.236%
11/3/2023	Richmond Brothers Inc.	368,003	$1.23M	2.3%	+7.6%	1.752%
11/2/2023	Rice Hall James & Associates LLC	828,628	$2.78M	0.2%	-2.4%	3.944%
10/24/2023	Stratos Wealth Partners LTD.	23,925	$80K	0.0%	-51.4%	0.114%
10/12/2023	Legato Capital Management LLC	10,098	$34K	0.0%	-38.6%	0.048%
9/8/2023	Tucker Asset Management LLC	29,106	$0.13M	0.0%	N/A	0.139%
8/11/2023	O Shaughnessy Asset Management LLC	11,525	$50K	0.0%	N/A	0.055%
8/10/2023	Private Advisor Group LLC	10,200	$44K	0.0%	-49.0%	0.049%
8/7/2023	Acadian Asset Management LLC	28,245	$0.12M	0.0%	N/A	0.135%
8/2/2023	MAI Capital Management	485,048	$2.11M	0.0%	-1.9%	2.315%
7/24/2023	Rice Hall James & Associates LLC	849,286	$3.69M	0.2%	+5.0%	4.054%
7/18/2023	Stratos Wealth Partners LTD.	49,195	$0.21M	0.0%	N/A	0.235%
7/13/2023	Thompson Davis & CO. Inc.	18,188	$79K	0.1%	N/A	0.087%
7/10/2023	Trust Co. of Toledo NA OH	32,399	$0.14M	0.0%	+24.6%	0.155%
5/12/2023	Rice Hall James & Associates LLC	809,117	$3.03M	0.2%	+0.4%	3.863%
5/10/2023	Richmond Brothers Inc.	340,526	$1.28M	2.2%	+3.5%	1.625%
5/10/2023	MAI Capital Management	494,690	$1.86M	0.0%	+12.4%	2.361%
4/4/2023	Trust Co. of Toledo NA OH	26,000	$98K	0.0%	N/A	0.124%
2/9/2023	MAI Capital Management	440,071	$1.55M	0.0%	+23.3%	2.115%
2/8/2023	Lincoln National Corp	11,600	$41K	0.0%	N/A	0.056%
2/8/2023	Richmond Brothers Inc.	328,970	$1.16M	1.6%	+2.7%	1.581%
2/1/2023	Legato Capital Management LLC	16,456	$58K	0.0%	N/A	0.079%
1/27/2023	Rice Hall James & Associates LLC	806,067	$2.85M	0.2%	+49.2%	3.874%
1/18/2023	Private Advisor Group LLC	20,000	$71K	0.0%	N/A	0.096%
11/8/2022	Bedel Financial Consulting Inc.	15,000	$31K	0.0%	N/A	0.073%
11/2/2022	Richmond Brothers Inc.	320,332	$0.64M	0.7%	+3.0%	1.557%
11/1/2022	Rice Hall James & Associates LLC	540,348	$1.09M	0.1%	+65.0%	2.626%
8/12/2022	Richmond Brothers Inc.	311,120	$0.60M	0.6%	+149.8%	1.607%
8/11/2022	Warberg Asset Management LLC	24,200	$46K	0.0%	N/A	0.125%
8/8/2022	Rice Hall James & Associates LLC	327,494	$0.63M	0.0%	+125.8%	1.691%
7/19/2022	Eidelman Virant Capital	25,000	$48K	0.0%	N/A	0.129%
5/9/2022	Powell Investment Advisors LLC	13,500	$44K	0.0%	N/A	0.070%
5/5/2022	MCF Advisors LLC	9,499	$31K	0.0%	N/A	0.049%
5/5/2022	Richmond Brothers Inc.	124,544	$0.40M	0.3%	+67.4%	0.647%
4/18/2022	Spire Wealth Management	9,002	$29K	0.0%	N/A	0.047%
2/14/2022	Rice Hall James & Associates LLC	132,433	$0.49M	0.0%	N/A	0.766%
2/14/2022	Diametric Capital LP	89,442	$0.33M	0.3%	N/A	0.517%
2/10/2022	Richmond Brothers Inc.	74,420	$0.28M	0.2%	N/A	0.430%
2/4/2022	Frontier Wealth Management LLC	18,000	$67K	0.0%	-28.0%	0.104%
8/25/2021	Marshall Wace LLP	329,131	$1.74M	0.0%	N/A	1.948%
8/17/2021	Man Group plc	14,900	$79K	0.0%	N/A	0.119%
8/16/2021	Squarepoint Ops LLC	19,395	$0.10M	0.0%	+87.1%	0.154%
8/16/2021	Occudo Quantitative Strategies LP	23,445	$0.12M	0.0%	N/A	0.187%
8/16/2021	State Street Corp	54,573	$0.29M	0.0%	N/A	0.434%
8/16/2021	Goldman Sachs Group Inc.	37,315	$0.20M	0.0%	N/A	0.297%
8/16/2021	Marshall Wace LLP	329,131	$1.74M	0.0%	N/A	2.620%
8/13/2021	Renaissance Technologies LLC	35,529	$0.19M	0.0%	-68.7%	0.283%
8/13/2021	Geode Capital Management LLC	25,594	$0.14M	0.0%	+126.5%	0.204%
8/13/2021	Vanguard Group Inc.	37,146	$0.20M	0.0%	+170.7%	0.296%
8/11/2021	Susquehanna International Group LLP	59,172	$0.31M	0.0%	N/A	0.471%
8/11/2021	Susquehanna Fundamental Investments LLC	16,441	$87K	0.0%	N/A	0.131%
5/25/2021	Regency Capital Management Inc. DE	17,000	$99K	0.1%	N/A	0.135%
5/19/2021	Squarepoint Ops LLC	10,365	$60K	0.0%	-47.0%	0.082%
5/18/2021	Millennium Management LLC	12,692	$74K	0.0%	N/A	0.101%
5/17/2021	Ikarian Capital LLC	119,551	$0.69M	0.0%	N/A	0.952%
5/13/2021	Renaissance Technologies LLC	113,620	$0.66M	0.0%	+53.9%	0.904%
5/12/2021	Geode Capital Management LLC	11,300	$65K	0.0%	N/A	0.090%
5/12/2021	Pura Vida Investments LLC	57,536	$0.33M	0.0%	N/A	0.458%
5/6/2021	Altium Capital Management LP	397,036	$2.31M	0.6%	-80.8%	3.379%
4/30/2021	Norris Perne & French LLP MI	78,909	$0.46M	0.0%	N/A	0.722%
2/16/2021	Squarepoint Ops LLC	19,572	$0.13M	0.0%	N/A	0.180%
2/10/2021	Renaissance Technologies LLC	73,820	$0.48M	0.0%	N/A	6.585%
1/28/2021	Comerica Bank	30,000	$0.32M	0.0%	N/A	2.676%

Data available starting January 2016

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was founded in 2018 and is headquartered in Farmington Hills, Michigan.

Today's Range

Now: $1.54

$1.51

$1.58

50 Day Range

MA: $2.14

$1.51

$2.65

52 Week Range

Now: $1.54

$1.50

$6.60

Volume

140,421 shs

Average Volume

220,787 shs

Market Capitalization

$38.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.34

Who are the company insiders with the largest holdings of Ocuphire Pharma?: Ocuphire Pharma's top insider shareholders include:
George Magrath (CEO)
Mina Sooch (CEO)
Nirav S Jhaveri (CFO)
James S J Manuso (Director)
Joseph K Schachle (COO)
Learn More about top insider investors at Ocuphire Pharma.